Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Psychiatry and Clinical Neurosciences|October 10, 2013
Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive functionShin Ogino, Seiya Miyamoto, Nobumi Miyake, et al.
Upsala Journal of Medical Sciences|September 17, 2011
Recurrent dislocation of the patella accompanying hypotrochlea of the femur and malalignment of the patellaAkira Horikawa, Hiroyuki Kodama, Naohisa Miyakoshi, et al.
Brain Research|September 25, 2002
Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor functionGary Duncan, Seiya Miyamoto, Hongbin Gu, et al.
Modern Rheumatology|September 19, 2015
Prevalence of and factors associated with lumbar spondylolisthesis in patients with rheumatoid arthritisYusuke Sugimura, Naohisa Miyakoshi, Seiya Miyamoto, et al.
Neuropsychiatric Disease and Treatment|June 15, 2013
Profile of blonanserin for the treatment of schizophreniaTomomi Tenjin, Seiya Miyamoto, Yuriko Ninomiya, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|September 15, 2018
The effect of morphine added to periarticular multimodal drug injection or spinal anesthesia on pain management and functional recovery after total knee arthroplastySeiya Miyamoto, Takehiko Sugita, Toshimi Aizawa, et al.
The Knee|June 2, 2024
Should central osteophytes within the articular cartilage of the lateral compartment be considered when determining the indication of unicompartmental knee arthroplasty for medial osteoarthritis?Takehiko Sugita, Naohisa Miyatake, Seiya Miyamoto, et al.
Molecular Interventions|March 3, 2004
Recent advances in the neurobiology of schizophreniaSeiya Miyamoto, Anthony S LaMantia, Gary E Duncan, et al.
Psychiatry and Clinical Neurosciences|May 20, 2014
Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: a 1-year open-label trialYuriko Ninomiya, Seiya Miyamoto, Tomomi Tenjin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 7, 2004
Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunctionSeiya Miyamoto, John N Snouwaert, Beverly H Koller, et al.
Pageof 3